Clinical Trials Browser

Phase 1/2 × Terminated × Advanced Cancer × Clear all

NCT03446040 2025-09-18

An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread

Phase 1/2 Terminated

92 enrolled 31 charts

Advanced Cancer

NCT05154630 2024-01-18

Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors

Phase 1/2 Terminated

Advanced Cancer